FDA Clears Alzheimer’s Blood Test for Adults as Young as 40
The FDA has cleared the first blood-based Alzheimer’s test authorized for symptomatic adults as young as 40.
Read MorePosted by CLP Edit Staff | Aug 21, 2026 | Dementias & Alzheimer’s, Mass Spectrometry |
The FDA has cleared the first blood-based Alzheimer’s test authorized for symptomatic adults as young as 40.
Read MorePosted by CLP Edit Staff | Aug 18, 2026 | Company News, Diabetes & Metabolic Diseases, Information Technology |
Century Health and GI Partners of Illinois have partnered to create a real-world data ecosystem for IBD and MASH, leveraging AI to extract clinical insights from lab data, pathology reports, and imaging to support research and pharmaceutical innovation.
Read MorePosted by CLP Edit Staff | Aug 13, 2026 | Clinical Chemistry |
Researchers have launched LipidLibrarian, an open-source tool that integrates data from major lipid databases to streamline diagnostic marker identification.
Read MorePosted by CLP Edit Staff | Aug 10, 2026 | Prenatal Testing |
Revvity has launched the SuperFlex prenatal screening system, a CE-IVDR certified immunoassay instrument for small and mid-sized labs, supporting preeclampsia and biochemical screening in low-volume workflows, the company announced.
Read MorePosted by CLP Edit Staff | Aug 4, 2026 | Cancer, Molecular Diagnostics |
Researchers at Johns Hopkins validated an AI-powered blood test that accurately detects liver cancer in diverse populations, using the DELFI platform to analyze cell-free DNA fragments.
Read More